Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2016 1
2017 1
2018 11
2019 16
2020 3
Text availability
Article attribute
Article type
Publication date

Search Results

28 results
Results by year
Filters applied: . Clear all
Page 1
Use of anastrozole for breast cancer prevention (IBIS-II): long-term results of a randomised controlled trial.
Cuzick J, Sestak I, Forbes JF, Dowsett M, Cawthorn S, Mansel RE, Loibl S, Bonanni B, Evans DG, Howell A; IBIS-II investigators. Cuzick J, et al. Lancet. 2020 Jan 11;395(10218):117-122. doi: 10.1016/S0140-6736(19)32955-1. Epub 2019 Dec 12. Lancet. 2020. PMID: 31839281 Free PMC article. Clinical Trial.
Overall Survival with Fulvestrant plus Anastrozole in Metastatic Breast Cancer.
Mehta RS, Barlow WE, Albain KS, Vandenberg TA, Dakhil SR, Tirumali NR, Lew DL, Hayes DF, Gralow JR, Linden HH, Livingston RB, Hortobagyi GN. Mehta RS, et al. N Engl J Med. 2019 Mar 28;380(13):1226-1234. doi: 10.1056/NEJMoa1811714. N Engl J Med. 2019. PMID: 30917258 Free PMC article. Clinical Trial.
Use of an aromatase inhibitor in children with congenital adrenal hyperplasia: Impact of anastrozole on bone mineral density and visceral adipose tissue.
Halper A, Sanchez B, Hodges JS, Dengel DR, Petryk A, Sarafoglou K. Halper A, et al. Clin Endocrinol (Oxf). 2019 Jul;91(1):124-130. doi: 10.1111/cen.14009. Epub 2019 May 15. Clin Endocrinol (Oxf). 2019. PMID: 31070802
PARAGON: A Phase II study of anastrozole in patients with estrogen receptor-positive recurrent/metastatic low-grade ovarian cancers and serous borderline ovarian tumors.
Tang M, O'Connell RL, Amant F, Beale P, McNally O, Sjoquist KM, Grant P, Davis A, Sykes P, Mileshkin L, Moujaber T, Kennedy CJ, deFazio A, Tan K, Antill Y, Goh J, Bonaventura T, Scurry J, Friedlander M. Tang M, et al. Gynecol Oncol. 2019 Sep;154(3):531-538. doi: 10.1016/j.ygyno.2019.06.011. Epub 2019 Jun 18. Gynecol Oncol. 2019. PMID: 31227223 Clinical Trial.
Patient-reported predictors of early treatment discontinuation: treatment-related symptoms and health-related quality of life among postmenopausal women with primary breast cancer randomized to anastrozole or exemestane on NCIC Clinical Trials Group (CCTG) MA.27 (E1Z03).
Wagner LI, Zhao F, Goss PE, Chapman JW, Shepherd LE, Whelan TJ, Mattar BI, Bufill JA, Schultz WC, LaFrancis IE, Nagargoje GG, Vemuri R, Nikcevich DA, Sledge GW, Cella D. Wagner LI, et al. Breast Cancer Res Treat. 2018 Jun;169(3):537-548. doi: 10.1007/s10549-018-4713-2. Epub 2018 Feb 17. Breast Cancer Res Treat. 2018. PMID: 29455298 Free PMC article.
Fulvestrant plus anastrozole for metastatic breast cancer.
Burki TK. Burki TK. Lancet Oncol. 2019 May;20(5):e247. doi: 10.1016/S1470-2045(19)30217-7. Epub 2019 Apr 4. Lancet Oncol. 2019. PMID: 30956120 No abstract available.
In case of anastrozole-related hallucinations, can switching to letrozole be a treatment option? A case report and literature review.
Bozkaya Y, Erdem GU, Demirci NS. Bozkaya Y, et al. J Oncol Pharm Pract. 2019 Apr;25(3):754-757. doi: 10.1177/1078155218762626. Epub 2018 Mar 14. J Oncol Pharm Pract. 2019. PMID: 29536789 Review.
Early participant-reported symptoms as predictors of adherence to anastrozole in the International Breast Cancer Intervention Studies II.
Sestak I, Smith SG, Howell A, Forbes JF, Cuzick J. Sestak I, et al. Ann Oncol. 2018 Feb 1;29(2):504-509. doi: 10.1093/annonc/mdx713. Ann Oncol. 2018. PMID: 29126161 Free PMC article. Clinical Trial.
Association of Crystalline Retinopathy With Anastrozole.
Wieder MS, Harooni M, Rusu I. Wieder MS, et al. JAMA Ophthalmol. 2019 May 1;137(5):581-582. doi: 10.1001/jamaophthalmol.2019.0064. JAMA Ophthalmol. 2019. PMID: 30816942 No abstract available.
Anastrozole-induced pulmonary cryptococcosis in a patient with early breast cancer: A case report.
Wei M, Xu YR, Liu K, Wen P. Wei M, et al. Medicine (Baltimore). 2020 Jan;99(2):e18688. doi: 10.1097/MD.0000000000018688. Medicine (Baltimore). 2020. PMID: 31914067 Free PMC article.
28 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback